HH Biotechnology Holdings

HHBT · OTC

$0.0001−$0.0001 (−50.00%)TodayMarket closed · Nov 3, 1:44 PM ET

No price history for this range.

About HHBT

HH Biotechnology Holdings Co. through its various subsidiaries, is engaged in the commercial and residential real estate leasing, management, consulting, investment, development and sales in the city of Shenyang, Liaoning Province, in the People' Republic of China. The company is headquartered in Shenyang, Liaoning. The company went IPO on 2012-07-23. The firm operates through two segments. The Property for Sale segment is primarily engaged in real estate sales. The Rental Income and Income of Management Fee of Commercial Buildings segment is primarily engaged in rental income and management fee income of commercial buildings. The firm conducts all operations through its direct and indirect subsidiaries, which include Shenyang Maryland International Industry Company Limited and Silverstrand International Holdings Company Limited. The firm is focused primarily on real estate leasing, management and consulting activities in the city of Shenyang.

Employees: 0
Headquarters: Shenyang, Liaoning
Listed: Jul 23, 2012
Sector: Real Estate
Industry: Real Estate Management & Development
Website: greatchinaholdings.com

Leadership

HH Biotechnology Holdings executives
Name	Title	Since	Age
Frank Jiang	—	2005	62
Sheng Jiang	—	2016	—
Lirong Wang	—	2005	54
Liang Zou	—	—	—
Sasaki Koji	—	—	—
Kunpeng Yu	—	—	—
Shuang Li	—	—	—
Huang Ying	—	—	—
Yizhao Zhang	—	—	54

Similar companies

Companies in the same industry as HH Biotechnology Holdings

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.